These results, together with univariate and multivariate Cox regression analysis of the Mannheim and the TCGA cohort, suggest that TLE2 could serve as an independent risk factor for prognostic prediction of patients with BLCA. This evidence concerns the gene TLE2 and bladder transitional cell carcinoma.